![\"Everlab\"](\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/06\/Marc-Hermann-CEO_logo.jpg\"){kind=logo}
Everlab co-founder and CEO Marc Hermann.<\/p>\n\t\t\t\t\t\t\tPublished on\t\t\t\t\t\t<\/p>\n
\t\t\t\t\t\t\tJune 17, 2026\n\t\t\t\t\t<\/p>\n
Marc Hermann set out to build a healthcare company focused on catching disease before it strikes. Investors have backed that vision with a $65 million funding round.<\/p>\n
Everlab co-founder and CEO Marc Hermann.<\/p>\n
Everlab has raised $65 million at a valuation approaching $500 million, marking what appears to be Australia\u2019s largest medtech capital raise of the year, cementing the Melbourne-based preventive healthcare startup as one of the country\u2019s fastest-growing tech companies.<\/p>\n
For co-founder and chief executive Marc Hermann, however, the company\u2019s mission began long before investors were writing eight-figure cheques.<\/p>\n
When Hermann was 13, his father collapsed and died in his mid-40s from a sudden heart attack shortly after finishing a half-marathon. <\/p>\n
\u201cIt was one of those unfortunately way too common cases,\u201d says Hermann, 37. \u201cVery healthy from the outside, zero warning signals, and then from one day to the other he was gone.\u201d<\/p>\n
\u201cWe weren\u2019t planning on raising. Usually that\u2019s the best catalyst for a good round \u2014 when you don\u2019t need the money.\u201d<\/p>\n
Marc Hermann, Everlab CEO<\/p>\n
The loss stayed with Hermann through a career that took him from German startup Rocket Internet to southeast Asian ecommerce giant Lazada and eventually to the sale of his own nutrition and fitness company, Foodspring, to confectionery giant Mars in 2019.<\/p>\n
After moving to Sydney with his Australian wife, Hermann initially intended to take a break from startups, but found himself searching for a new venture that felt meaningful.<\/p>\n
He found it when he met Dr Steven Lu, Anshul Jain and Sam Kothari, who had similar stories<\/a> of premature illness and death of people close to them. They had a vision for scaling Lu\u2019s small suburban practice with an app, a subscription model and outsourced testing focused on taking the surprises out of health.<\/p>\n They founded Everlab in 2023.<\/p>\n Everlab raised $15 million in a seed round announced in July 2025. In the 11 months since, revenue has grown tenfold, Hermann says, servicing 20,000 patients over 40,000 consultations. \u201cWe have more than 180 clinicians [90 doctors, plus dieticians and physiotherapists] working for us, and we integrate into more than 1,800 physical locations across Australia \u2026 everything from pathology, radiology, specialist partners, plus things like genetic testing and microbiome testing.\u201d<\/p>\n The latest $65 million funding round was not part of Everlab\u2019s original plans. Hermann says the company had barely touched the capital raised in its previous round and was focused on executing its growth strategy when investor interest began to intensify.<\/p>\n \u201cWe weren\u2019t planning on raising,\u201d he says. \u201cUsually that\u2019s the best catalyst for a good round \u2014 when you don\u2019t need the money.\u201d<\/p>\n The groundwork had been laid during the company\u2019s 2025 raise, when Everlab spoke with a wide range of venture investors before ultimately choosing US-based Left Lane Capital. According to Hermann, Left Lane stood out because of its understanding of preventive healthcare and the evolution of similar models in the United States.<\/p>\n The company continued sharing updates with investors it had not selected, circulating quarterly board materials and performance metrics. As Everlab\u2019s growth accelerated, so did investor attention.<\/p>\n That culminated in venture capital firm Airtree Ventures approaching Everlab with a term sheet, seeking to lead a larger financing round. It was joined by Left Lane, London tech investor Plural, Europe\u2019s b2venture and angel investors including Australian Test Captain Pat Cummins. It is the largest medtech raise in Australia since Heidi Health\u2019s $98 million Series B<\/a> in October 2025.<\/p>\n A significant portion of the funding will be directed towards technology and artificial intelligence. \u201cThings we\u2019re doing today simply weren\u2019t possible a year ago,\u201d he says. <\/p>\n Historically, healthcare has been a challenging sector for venture-backed businesses because of complex regulations and high wage costs for doctors. Hermann argues AI has the potential to change that.<\/p>\n Over the past six months, Everlab has already expanded its engineering team from fewer than 10 to 25 and the new money will accelerate that, says Hermann.<\/p>\n The second priority is expanding into\u00a0 United Kingdom, a market Hermann believes shares many similarities with Australia\u2019s healthcare system while facing growing pressure on public health services.<\/p>\n \u201cIn the UK, you have an interesting point in time where the NHS [National Health Service] is in a much worse state than Medicare is in Australia. Therefore, you see a lot of movement of people going more private and looking for new solutions because you have a massive, massive, massive care problem right now on the market.\u201d<\/p>\n Other markets will follow but he says the decision on which hasn\u2019t been made yet.<\/p>\n While not disclosing the founders\u2019 equity positions, he said they still controlled the board. \u201cSo we still control the business.\u201d<\/p>\n \u201cThe cool thing is like not only did we get him this heart scan, we got him an appointment for the surgery within 36 hours that removed the blockage.\u201d<\/p>\n Marc Hermann<\/p>\n Hermann says that while many companies are offering one or two aspects of what Everlab offers, like OneMRI<\/a>, or the multitude of labs and apps offering testing and analysis, none offered the full suite.<\/p>\n Everlab had grown into what he claims as a \u201cfull-blown health ecosystem where, under one hood, you get access to everything you need to manage your health \u2026 but also the vision, the dream, the scope of the business has evolved quite a lot, and hence the high valuation and the big funding round.\u201d<\/p>\n The labs and testing are outtsouced, but brought in-house through an app connecting to its 180 medical staff.<\/p>\n Hermann says they\u2019re saving lives.<\/p>\n \u201cIn 2025, we had 114 urgent \u2013 basically life-saving \u2013 findings, which is very humbling. But it really fires us up as founding team and for our employees.\u201d<\/p>\n A recent case hit home. \u201cWe had someone just three weeks ago with a very similar story to my dad,\u201d says Hermann. \u201cTriathlete, 43, very fit from the outside. We ran some bloods on him, saw increased genetic risk for heart disease, got him to do a CT coronary angiogram. We found deep blockages in the heart arteries. Heart attack looming basically.<\/p>\n \u201cNow, with any other providers and other startups out there, they wouldn\u2019t have even gotten you to the heart-scan stage, but if they did, they probably would have just handed you over. \u2018Find a GP to deal with it yourself.\u2019<\/p>\n \u201cBut for us, the cool thing is like not only did we get him this heart scan, we got him an appointment for the surgery within 36 hours that removed the blockage, did a stent, and now he\u2019s living well.<\/p>\n \u201cThis idea of like, \u2018Hey, we are the place you go for your health needs, and we will see things through end-to-end,\u2019 is something that\u2019s very hard to do, and therefore not many are doing it. There\u2019s a lot of partial overlap, but I don\u2019t think anyone is doing the real end-to-end solution like we are.\u201d<\/p>\n He said they\u2019re saving more lives long term by getting people to change their lifestyle habits, dropping body fat and gaining muscle. \u201cWe will over the next couple of months go a lot deeper into publishing our own medical research. We\u2019re really seeing very, very encouraging data points.\u201d<\/p>\n Want to see more Forbes articles on your feed?\u00a0Tap here to make Forbes Australia a preferred source on Google.<\/a><\/p>\n Look back on the week that was with hand-picked articles from Australia and around the world.\u00a0Sign up to the Forbes Australia newsletter here<\/a>\u00a0or\u00a0become a member here<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Published on June 17, 2026 Marc Hermann set out to build a healthcare company focused on catching disease…\n","protected":false},"author":2,"featured_media":742111,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[64,63,99,137,500,5476],"class_list":["post-742110","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-au","tag-australia","tag-business","tag-health","tag-healthcare","tag-investing"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/742110","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/comments?post=742110"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/posts\/742110\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media\/742111"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/media?parent=742110"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/categories?post=742110"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/au\/wp-json\/wp\/v2\/tags?post=742110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![\"Everlab\"](\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/06\/2_013a60.png\")
Dr Steven Lu in a consult.<\/p>\n![\"Everlab\"](\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/06\/VO2.jpg\")
Customers undergo a wide range of tests.<\/p>\n![\"\"](\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/06\/9.png\")
Everab\u2019s app at work.<\/p>\n![\"Everlab\"](\"https:\/\/www.newsbeep.com\/au\/wp-content\/uploads\/2026\/06\/3_7710dd.png\")
Everlab founding team: Dr Steven Lu, left, Sam Kothari, Anshul Jain and Marc Hermann.<\/p>\n